A new law in Maryland is creating a stir in health policy circles across the country as the debate escalates over the future of employer-based health coverage. Last month, the Maryland legislature approved a bill that basically requires Wal-Mart Stores to spend at least 8% of its payroll on employee healthcare or pay the difference to support the state Medicaid program. Union leaders and consumer advocates who backed the measure predict that it will generate similar action in many state capitols.
WASHINGTON, D.C.-A new law in Maryland is creating a stir in health policy circles across the country as the debate escalates over the future of employer-based health coverage. Last month, the Maryland legislature approved a bill that basically requires Wal-Mart Stores to spend at least 8% of its payroll on employee healthcare or pay the difference to support the state Medicaid program. Union leaders and consumer advocates who backed the measure predict that it will generate similar action in many state capitols.
Business organizations blasted the bill as doing little to expand access to healthcare for the uninsured and talked about challenging the legality of the new coverage mandate. While the Maryland law applies to employers with more than 10,000 workers, other states are looking at measures that may set a mandate on firms with only 1,000 or 2,000 employees, which could affect retail and restaurant chains.
The Maryland action reflects broader national concern about eroding employer health benefits. Wal-Mart has been under attack in particular for failing to provide coverage for half of its U.S. employees, which include many part-timers. However, employers note that most of the uninsured who have jobs work for small companies with fewer than 10 workers.
According to AHRQ, only 28% of American workers were offered plans in 2003 that do not require them to pay a portion of the health insurance premium, down from 35% in 1998. More than half of workers at small companies have access to no-premium coverage, compared with about one-fifth at large firms.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More